Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MOLOGEN-AG-137315091/news/Mologen-AG-Announces-Initiation-of-Phase-III-IMPALA-Study-with-Immunotherapy-MGN1703-in-Colorectal-C-38607702/?utm_source=whatsapp&utm_medium=social&utm_campaign=share